Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEVAR vs OMT for Type B Aortic Intramural Hematoma
NCT04808661Unknown
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Mar 2021
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
Randomised, open-label trial in Aortic intramural hematoma (IMH), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Incidence of aortic-related events at 1 year. Status: unknown.
02
Conditions
Aortic intramural hematoma (IMH)
Beyond the preview
Go deeper on NCT04808661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04808661.